MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalledMarch 22, 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalledMarch 22, 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Coming Soon: ‘Wegovy HD’March 21, 2026 Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalledMarch 20, 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Ozempic is getting generics as low as $15 — what it means for AmericansMarch 19, 2026 The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
NNutrition Read More Defining ‘ultraprocessed’ could spur research, school lunch rules – Roll CallMarch 19, 2026 The Trump administration is nearing a key milestone in its “Make America Healthy Again” agenda: proposing a definition of…
NNutrition Read More Protein Bar Lawsuit Questions Viral 150-Calorie ClaimMarch 17, 2026 When 28 grams of protein and 150 calories built a viral brand, a lawsuit argues whether the math…
NNutrition Read More Multivitamin Recall Update for 25 States As FDA Sets Risk LevelMarch 14, 2026 A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
MMedication Read More FDA sends letter to Novo Nordisk over potential GLP-1 side effectsMarch 13, 2026 The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…